Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $479.0900 (-2.04%) ($477.8400 - $479.0900) on Thu. Dec. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 30 | Latest Price | $479.0900(-2.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.8% a day on average for past five trading days. | Weekly Trend | REGN declines -2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) SPLV(36%) SPY(36%) DIA(35%) | Factors Impacting REGN price | REGN will decline at least -1.035% in a week (0% probabilities). VIXM(-21%) TBT(-7%) VXX(-6%) UUP(-6%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $514.4 | 5 Day Moving Average | $490.68(-2.36%) | 10 Day Moving Average | $499.47(-4.08%) | 20 Day Moving Average | $514.4(-6.86%) | To recent high | -21.2% | To recent low | 0% | Market Cap | $50.797b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |